tradingkey.logo

SNWV

SNWV
25.830USD
+0.270+1.06%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
221.52MCap. mercado
PérdidaP/E TTM

Más Datos de SANUWAVE Health Inc Compañía

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

Información de SNWV

Símbolo de cotizaciónSNWV
Nombre de la empresaSANUWAVE Health Inc
Fecha de salida a bolsaNov 07, 2008
Director ejecutivoFrank (Morgan C)
Número de empleados46
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 07
Dirección9600 W. 6Th Sstreet
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344
Teléfono19526561029
Sitio Webhttps://sanuwave.com/
Símbolo de cotizaciónSNWV
Fecha de salida a bolsaNov 07, 2008
Director ejecutivoFrank (Morgan C)

Ejecutivos de SNWV

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
-8642.00%
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
+2026.00%
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
+41.00%
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
+37.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-8447.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--
Mr. Morgan C. Frank
Mr. Morgan C. Frank
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Peter Sorensen
Mr. Peter Sorensen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timothy Wern
Mr. Timothy Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
--
--
Mr. Gregory (Greg) Bazar
Mr. Gregory (Greg) Bazar
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
-8642.00%
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
+2026.00%
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
+41.00%
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
+37.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-8447.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--

Desglose de ingresos

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States (Country)
11.45M
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 6 de feb
Actualizado: vie., 6 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Opaleye Management Inc.
11.43%
Manchester Management Company, L.L.C.
10.82%
AWM Investment Company, Inc.
5.30%
The Vanguard Group, Inc.
5.19%
BlackRock Institutional Trust Company, N.A.
5.13%
Otro
62.13%
Accionistas
Accionistas
Proporción
Opaleye Management Inc.
11.43%
Manchester Management Company, L.L.C.
10.82%
AWM Investment Company, Inc.
5.30%
The Vanguard Group, Inc.
5.19%
BlackRock Institutional Trust Company, N.A.
5.13%
Otro
62.13%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
24.80%
Investment Advisor
12.97%
Investment Advisor/Hedge Fund
11.68%
Individual Investor
1.33%
Research Firm
1.11%
Bank and Trust
0.21%
Pension Fund
0.13%
Insurance Company
0.03%
Otro
47.72%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
109
4.37M
50.95%
-566.32K
2025Q3
88
4.71M
54.97%
+846.01K
2025Q2
48
4.81M
56.23%
+1.02M
2025Q1
33
4.13M
48.25%
+281.09K
2024Q4
13
3.70M
91.09%
+2.41M
2024Q3
12
1.26M
39.85%
+274.18K
2024Q2
13
983.35K
31.89%
-13.84K
2024Q1
14
960.39K
31.58%
-14.91K
2023Q4
15
1.16M
53.72%
+592.61K
2023Q3
15
916.49K
50.29%
+506.92K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Opaleye Management Inc.
980.00K
11.43%
+35.87K
+3.80%
Sep 30, 2025
Manchester Management Company, L.L.C.
927.98K
10.82%
-162.81K
-14.93%
Dec 12, 2025
AWM Investment Company, Inc.
454.55K
5.3%
-58.68K
-11.43%
Sep 30, 2025
The Vanguard Group, Inc.
440.28K
5.13%
-4.52K
-1.02%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
439.85K
5.13%
+96.82K
+28.23%
Sep 30, 2025
Solas Capital Management, LLC
201.30K
2.35%
-382.74K
-65.53%
Sep 30, 2025
Geode Capital Management, L.L.C.
161.88K
1.89%
+4.15K
+2.63%
Sep 30, 2025
State Street Investment Management (US)
137.81K
1.61%
+72.10K
+109.72%
Sep 30, 2025
CenterBook Partners LP
87.95K
1.03%
+73.96K
+528.73%
Sep 30, 2025
Northern Trust Investments, Inc.
59.53K
0.69%
-1.50K
-2.46%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Micro-Cap ETF
Proporción0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI